1. Catalogs
  2. Geneseeq
  3. Geneseeq Essencare_Lung cancer CDx

Geneseeq Essencare_Lung cancer CDx
1 /2Pages

Geneseeq Essencare_Lung cancer CDx

Geneseeq Essencare_Lung cancer CDx
1 /2Pages

Catalog excerpts

Geneseeq Essencare_Lung cancer CDx-1

COMPREHENSIVE GENOMIC PROFILING EssencareTMLung Cancer CDxNMPA-approvedAbout Essencare™^ The Essencare™ Lung Cancer CDx Panel is a focused genomic profiling solution for patients with advanced lung cancer using hybrid capture-based next-generation sequencing.The panel includes six key driver genes to support therapy selection with approved targeted treatments and eight clinically relevant genes to understand disease mechanisms and aid clinical decision-making for emerging therapeutics. fKey Features v/ Panel includes 14 core lung cancer genes: EGFR, ALK, ROS1, BRAF, KRAS, HER2, RET, MET, NRAS, PIK3CA, AKT1, PTEN, NF1, MEK1 v' Four CDx indicationsv' Fully validated for SNV, Indel, CNV, Fusion with high detection sensitivityCompanion diagnostics (CDx) indications Biomarker Prevalence in NSCLC NMPA-Approved Therapy EGFR exon 19 deletion & EGFR L858R 45%-55% Iressa® (gefitinib) Conmana® (icotinib) EGFR T790M >50% Tagrisso® (osimertinib) ALK rearrangements 5%-10% Xalkori® (crizotinib) Validated through large-scale clinical studies 'Z Comparative studies with gold-standard methods, including fluorescent PCR, FISH, and Sanger sequencing, showed an overall concordance rate above 98%. ^ Consistency analysis with approved EGFR, ALK, and ROS1 companion diagnostic kits demonstrated 100% overall agreement. Retrospective clinical studies: patients with EGFR sensitizing mutations or ALK/ROS1 fusions detected by Essencare achieved therapeutic outcomes consistent with those observed in prior clinical trials. Copyright © 2025. GENESEEQ Technology Inc. All rights reserved.

 Open the catalog to page 1
Geneseeq Essencare_Lung cancer CDx-2

COMPREHENSIVE GENOMIC PROFILING Sample Requirement Tumor Tissues: FFPE Slides: 5-15 slides (Or unstained slides of biopsy or surgical specimen) Extracted gDNA from fresh tissue or FFPE: at least 100 ng Turnaround Time Report expected in 5-7 days form sample receipt.‡ Variant Types Single Nucleotide Variants (SNVs) Small Insertion and Deletion Variants (indels) Gene Translocations IVD/RUO Reagent Kits Kits contain reagents required for entire NGS workflow Built-in analysis solutions Customer service Nucleic acid extraction Library preparation Targeted enrichment Validated workstation adpated for...

 Open the catalog to page 2
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.